Literature DB >> 7845674

Increased transforming activity of JunB and JunD by introduction of an heterologous homodimerization domain.

L Vandel1, C M Pfarr, S Huguier, L Loiseau, A Sergeant, M Castellazzi.   

Abstract

The closely-related proteins c-Jun, JunB and JunD form a family of transcription factors which require dimerization for DNA-binding and transcriptional activity. Dimerization is mediated by a conserved amphipathic alpha-helix located adjacent to a highly charged DNA-binding domain. The Jun proteins can form both homo- and heterodimers within the Jun family and can also cross-dimerize with the Fos proteins. When expressed at high levels in primary chicken cells, each mouse Jun displays distinct transforming capacities: c-Jun transforms efficiently, JunB transforms poorly, and JunD does not transform at all. The composition of the transforming dimers, however, is unknown. To study the activity of Jun-Jun homodimers we constructed artificial derivatives, denoted Juneb1, in which the naturally occurring dimerization domain has been replaced by an heterologous homodimerization domain from the Epstein-Barr virus transcription factor EB1. These derivatives were introduced into chicken cells and assayed for their ability to affect growth. Unexpectedly, all three Juneb1 proteins conferred a transformed phenotype to primary cultures, promoting sustained growth in low-serum medium and colony formation from single cells in agar. These data demonstrate that when forced to accumulate as homodimers, both JunB and JunD can transform cells. They also suggest that the poor transforming activity of JunB and the absence of transforming activity of JunD may be due to their inability to accumulate to high levels as homodimers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7845674

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  Immunological synapse: a multi-protein signalling cellular apparatus for controlling gene expression.

Authors:  Kartika Padhan; Rajat Varma
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

2.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.

Authors:  H van Dam; S Huguier; K Kooistra; J Baguet; E Vial; A J van der Eb; P Herrlich; P Angel; M Castellazzi
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

3.  Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family.

Authors:  M Hartl; K Bister
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

4.  Porins from Salmonella enterica serovar Typhimurium activate the transcription factors activating protein 1 and NF-kappaB through the Raf-1-mitogen-activated protein kinase cascade.

Authors:  Massimiliano Galdiero; Mariateresa Vitiello; Emma Sanzari; Marina D'Isanto; Annalisa Tortora; Anna Longanella; Stefania Galdiero
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Regulation of HGF-mediated cell proliferation and invasion through NF-κB, JunB, and MMP-9 cascades in stomach cancer cells.

Authors:  Kyung Hee Lee; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2012-01-18       Impact factor: 5.150

6.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization.

Authors:  L Vandel; N Montreau; E Vial; C M Pfarr; B Binetruy; M Castellazzi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  Function of hepatocyte growth factor in gastric cancer proliferation and invasion.

Authors:  Sung Ae Koh; Kyung Hee Lee
Journal:  Yeungnam Univ J Med       Date:  2020-02-20

9.  Small molecule inhibitors targeting activator protein 1 (AP-1).

Authors:  Na Ye; Ye Ding; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2014-05-27       Impact factor: 8.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.